A study of lopinavir/ritonavir (Kaletra), a combination of the antivirals lopinavir and ritonavir, concluded "no benefit was observed".
Utafiti mmoja wa lopinavir/ritonavir (Kaletra), mchanganyiko wa kinga virusi vya lopinavir na ritonavir, ulihitimisha kuwa &quot;hakuna faida ulioonekana&quot;.